Myung In Pharmaceutical LTD.

₩42,350As of Sun 8 Nov 2026, 12:00 UTC
KRX:317450Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR —
Div yield 2.36%
ROE 12.91%
Drug Manufacturers (General)
Beta (5Y) —
PE TTM 6.588
TSR TTM (46.80%)
Mkt cap ₩618.3B
ROIC 24.95%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩51,973
22.72%
(73.85%)
Buy 11|12|2|1|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
608.54
661.35
732.20
799.48
21.45%
30.65%
32.53%
40.97%
Revenue₩B
42.67
42.19
44.05
44.83
1.19%
(1.29%)
3.73%
4.08%
Peers (US$455.9M)
Cap (US$)
PE
529.1M
5.939x
499.0M
3.720x
482.5M
381.2x
Capital
TTM
5Y
10Y
Leveragex
0.054
0.237
0.172
EBIT/Intx
1.380
0.077
0.076
Own earn%
127.91
274.16
256.17
Sh yield%
33.46
56.94
54.15
Owners
Insiders/Inst%
8.47
59.26
Short interest%
1.53
SBC / revenue%
5.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
9–15
$1 testx
—
Incr. ROIC%
4